Impact of everolimus on Japanese patients with advanced pancreatic neuroendocrine neoplasms.
about
Dose and schedule modification are required for long-term continuation of sunitinib in Japanese patients with advanced pancreatic neuroendocrine tumors.Clinical outcomes of everolimus in patients with advanced, nonfunctioning pancreatic neuroendocrine tumors: a multicenter study in Korea.Everolimus-inhibited multiple isoforms of UDP-glucuronosyltransferases (UGTs).
P2860
Impact of everolimus on Japanese patients with advanced pancreatic neuroendocrine neoplasms.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Impact of everolimus on Japane ...... atic neuroendocrine neoplasms.
@en
Impact of everolimus on Japane ...... atic neuroendocrine neoplasms.
@nl
type
label
Impact of everolimus on Japane ...... atic neuroendocrine neoplasms.
@en
Impact of everolimus on Japane ...... atic neuroendocrine neoplasms.
@nl
prefLabel
Impact of everolimus on Japane ...... atic neuroendocrine neoplasms.
@en
Impact of everolimus on Japane ...... atic neuroendocrine neoplasms.
@nl
P2093
P2860
P356
P1476
Impact of everolimus on Japane ...... eatic neuroendocrine neoplasms
@en
P2093
Hisato Igarashi
Keijiro Ueda
Lingaku Lee
Takashi Fujiyama
Tetsuhide Ito
Yoshihiro Ogawa
P2860
P304
P356
10.1002/JHBP.418
P50
P577
2017-02-01T00:00:00Z